An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy

J Palliat Med. 2020 Nov;23(11):1424-1425. doi: 10.1089/jpm.2020.0355.

¹ Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
² Division of Hematology and Oncology, Columbia University Medical Center, New York, New York, USA.
³ Laura and Isaac Perlmutter Cancer Center, NYU School of Medicine, New York, New York, USA.
⁴ Oncology Social Work, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
⁵ Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

No abstract available

Publication types